Navigation Links
The X-Change Corporation To Announce Corporate Name Change Next Week; New Industry-Driven Branding to Commence For Global Activities, Services, Product Lines, and Website
Date:9/6/2013

COLORADO SPRINGS, Colo., Sept. 6, 2013 /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company specializing primarily in cannabinoid formulation-based health and wellness solutions, is pleased to announce that the Company's Board of Directors has carefully considered and affirmatively decided to change the name of the Company. The company share structure will remain the same, as there will be no consolidation or share split in this corporate action. The new Brand name will be announced next week and will better position the Company in the global medical cannabis market.

The new Company name will serve as the enhanced brand and refined image to be used in conjunction with all of its activities, products, and services.  Dispensary owners will be licensed to use the Company's brands and formulations for retail distribution through licensing agreements. 

Through the current Medbox agreement, the Company expects to enter into ten additional management agreements with the owners of dispensary and cultivation operations in the states of Arizona, California, Illinois, Massachusetts, Nevada, and Washington State.  Building on the new Company name, this brand will also serve as the primary name of international subsidiaries and their operations globally, for products already set for release, for various new products and services under study or development, and for worldwide website and social media modalities.

Specifically, initial regulatory steps to effectuate the name change have begun in order to maximize the branding of the Company's launch of its Arizona dispensary management and of its management operations pursuant to the agreement with Medbox, Inc. regarding legal medical cannabis dispensary and cultivation facilities around the country.

"We are very excited about the upcoming corporate name change. The Company's branding is a critical component in our messaging and will provide an enhanced platform for the important work that the Company is undertaking for the benefit of science, solutions for patients, and the integrity of the markets," stated Robert Kane, CFO and Senior Vice President for Business Development of XCHC.  Mr. Kane continued, "We expect to announce the new name and branding campaign next week."

About The X-Change Corporation
The X-Change Corporation is currently developing new natural cannabinoid containing products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis and hemp have been known and applied for thousands of years. With the aid of scientific research, The X-Change Corporation is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company's health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. X-Change Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

The X-Change Corporation
President
Dr. Dorothy Bray
info@xchangecorp.com
www.xchangecorp.com
+1.866.326.5595

Investment Inquiries
Robert Kane
CFO, Sr VP of Business Development
rkane@xchangecorp.com
+1.561.420.4824


'/>"/>
SOURCE The X-Change Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. X-Change Corp. Delighted with DOJs Historic Shift Toward Non-Interference Within State Cannabis Regulatory Environments; Sees Green Light for Companys Patient-Driven Medical Cannabis Operations Under State Laws
2. X-Change Corporation Signs Multi-Million Dollar Agreement for Multi-State Product Release Licensing, Medical Cannabis Dispensary Management, and Cultivation Consulting
3. Medbox Signs Multi-State Consulting Deal with X-Change Corporation
4. X-Change Corporation Launches Upgraded Version of Phytiva Website, As Company Targets Distribution of Phytiva Product Line in United States and Worldwide, Extracts and New Products in Europe
5. Unilife Corporation To Announce Financial Results For Fiscal Year 2013 Fourth Quarter And Year End On Tuesday, September 10, 2013
6. Arrayit Corporation Holds Successful Meeting with DHK Medical Products CEO
7. MGC Diagnostics Corporation Reports 2013 Third Quarter Operating Results
8. Immune Pharmaceuticals Completes Merger with EpiCept Corporation
9. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
10. Xi3 Corporation Signs Collaboration Agreement with Intermountain Healthcare as Founding Member of Intermountains New Healthcare Transformation Lab
11. Ambit Biosciences Corporation Announces Second Quarter 2013 Operational Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... N.Y. , Dec. 6, 2016 ... a reason to be hopeful.  A special kind of ... a less anxious life. Photo - ... Robert Buck, the psychotherapist who developed and ... breakthrough approach to overcoming anxiety and worry.  "Anxiety ...
(Date:12/5/2016)... , Dec. 5, 2016  Zimmer Biomet Holdings, ... announced that, pursuant to its previously-announced cash tender ... in the table below (collectively, the "Notes"), approximately ... validly tendered and not validly withdrawn on or ... time, today, December 5, 2016 (the ...
(Date:12/5/2016)... France Glaucoma Surgery Devices Market Outlook to 2022 ... Market Outlook to 2022", provides key market data on ... value, in millions of US dollars, volume (in units) ... Micro Catheters and Glaucoma Drainage Devices. The report ... each of these market segements, and global corporate-level profiles ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... "ProBrand Flip allows FCPX editors ... said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip includes 30 ... drop zones. Editors can select from a variety of flip book animations. In Addition, ...
(Date:12/7/2016)... ... December 07, 2016 , ... Bioelectronic ... Plus for consumers and healthcare professionals to manage chronic and acute pain. ... treatment modalities available in a single device. The announcement is part of ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... “The Road ... is an everyday trial, not a one hour a week showing of hands. “The ... businessman. , Tom begins, “Perhaps you are familiar with the brass ring that you ...
(Date:12/7/2016)... ... ... With God: Inspirational Lessons from My Life's Journey”: a sometimes serious, sometimes humorous ... in their lives. “Walking With God: Inspirational Lessons from My Life's Journey” is the ... , Sanford says, “I enjoy sharing the true stories in my book as examples ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... ... for individuals impacted by cerebral cavernous angiomas, was awarded a grant from the ... patient engagement program. New Mexico has more people with cavernous angioma than anywhere ...
Breaking Medicine News(10 mins):